A database study to understand the current treatment patterns and efficacy of high-dose methotrexate-based therapy in Japanese patients with Primary central nervous system lymphoma
Not Applicable
- Conditions
- Primary central nervous system lymphoma
- Registration Number
- JPRN-UMIN000042120
- Lead Sponsor
- Ono Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients whose data period before the index is less than 6 months (183 days) - Patients with a follow-up period of less than 12 months (365 days) - Patients with a cancer recurrence flag on the initial hospitalization record etc.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method